The American Society of Hematology (ASH) is the world’s largest professional society serving clinicians and scientists who work to conquer blood diseases. This year the 62nd ASH Annual Meeting & Exposition – the premier conference in malignant and non-malignant hematology – will bring together approximately 25,000 hematology professionals from around the world virtually.
As always, our team is proud to contribute new lymphoma discoveries for presentation at the meeting. We’ll be covering the conference research updates on our social media channels and here on our blog throughout the duration of the meeting.
Dr. Peter Martin, Chief of the Weill Cornell Lymphoma Program shares some personal thoughts regarding the 2020 ASH Annual Meeting.
While it’s impossible to ignore the trauma that accompanied the year 2020, every December brings a display of the hopes and efforts of thousands of international researchers presenting their data at the Annual Meeting of the American Society of Hematology (ASH). I’m so proud to say that research is alive and well in the Lymphoma Program at Weill Cornell Medicine.
Over the next 3 days, our team of physicians and scientists will be presenting ground breaking research on the world’s top stage. Min Xia, PhD has the distinction of being selected to deliver a presentation in the ASH Plenary Session, the forum for the top 6 research abstracts of the entire conference. Dr. Ari Melnick is being honored for his work in epigenetics and will be delivering the prestigious Ernest Buetler lecture. We have numerous oral and poster presentations, including several from our fellows, residents, and medical students — the future leaders of our field.Peter Martin, MD, MS
Additionally, Dr. John Leonard continued his #LeonardList tradition of selecting 10 noteworthy lymphoma abstracts leading up to the meeting. In addition to posting his selections on Twitter, he discussed this research in detail in the third-annual Leonard List CancerCast Podcast episode – with 5 bonus podcast-only abstracts. Dr. Leonard selects this research from all the lymphoma-related abstracts, looking at both oral and poster sessions.